Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Stress inducible phosphoprotein 1 (STIP1) is a critical stemness regulator in mouse embryonic stem cells and early mammalian development

ABSTRACT: Stress-inducible phosphoprotein 1 (STIP1/STI1/HOP) is a co-chaperone that plays a pivotal role in proteostasis. Knockout of STIP1 leads to early embryonic lethality in mice, but its precise function in embryogenesis remains unknown. Thus, we mined single-cell RNA sequencing data from mouse embryos, finding that Stip1 is co-expressed with the core pluripotency transcription factors, highlighting a potential function of this protein in regulating stemness. This was confirmed by the derivation of mouse embryonic stem cell (mESC) lines from genetically-modified Stip1 mice. mESCs with decreased STIP1 levels presented low expression of essential pluripotency markers, impaired proliferation, and increased apoptosis and DNA damage. Conversely, mESCs overexpressing STIP1 showed elevated expression of stemness markers, enhanced proliferation, and reduced DNA damage and apoptosis. Finally, we reveal that cell cycle progression and DNA damage response proteins are altered in mESCs with differential STIP1 levels. Our work sheds light on the function of (antes era "on a novel function of") the co-chaperone STIP1 as a pivotal regulator of the pluripotent phenotype and embryogenesis.

ORGANISM(S): Mus musculus

PROVIDER: GSE303019 | GEO | 2025/07/25

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Secreted STIP1 stimulates cell proliferation of ovarian cancer through SMAD signaling pathways

Project description:Stress-induced phosphoprotein 1 (STIP1) is a co-chaperone that regulates other chaperone proteins that was recently shown to be secreted by ovarian cancer cells to induce cell proliferation. In this study, we found that STIP1 induced the phosphorylation of endogenous SMAD1/5, and knockdown of SMAD1/4/5 blocked STIP1-activated ID3 expression. Inhibition of ALK2, a serine/threonine kinase receptor, with siRNA or the specific inhibitor LDN193189, blocked STIP1-induced phosphorylation of SMAD1/5 and inhibited STIP1-related cell proliferation. The signaling pathway was found to involve binding of secreted STIP1 to ALK2, phosphorylation of SMAD, and activation of ID3 to induce cell proliferation was identified not only by in vitro immunofluorescent microscopy and biochemical identification of complex formation, but also by in vivo immunohistochemical analyses of ovarian cancer tissues. MDAH2774 cell treated with rhSTIP1 MDAH2774 cell treated without rhSTIP1 MDAH2774 cell treated with rhSTIP1-2 MDAH2774 cell treated without rhSTIP1-2

2012-03-03 | E-GEOD-27654 | biostudies-arrayexpress

Secreted STIP1 stimulates cell proliferation of ovarian cancer through SMAD signaling pathways

2012-03-03 | GSE27654 | GEO

rhSTIP1 induced SAMD1/5 pathway

Project description:Stress-induced phosphoprotein 1 (STIP1), a co-chaperone that organizes other chaperones- heat shock proteins (HSP), was recently shown to be secreted by human ovarian cancer cells to induce cell proliferation. In neuronal tissues, binding to prion protein was required for STIP1 to activate the ERK (extracellular regulated MAP kinase) signaling pathways. However, in this study, we found that STIP1 stimulated cell proliferation of ovarian cancer via a bone morphogenetic protein (BMP) signaling pathway, not through the prion-ERK pathway. The STIP1 binding to a BMP receptor, ALK2 (activin A receptor, type II-like kinase 2), was necessary and sufficient to stimulate cancer cell proliferation. The binding of STIP1 to ALK2 activated the SMAD signaling pathway, leading to transcriptional activation of ID3 (inhibitor of DNA binding 3) that promotes cell proliferation. In conclusion, ovarian cancer tissues secrete STIP1 into the local environment and eventually into blood circulation of patients. In an autocrine and/or paracrine fashion, secreted STIP1 stimulates cancer cell proliferation by binding to ALK2 and activating the SMAD-ID3 signaling pathways. Elucidation of the mechanism by which STIP1 stimulates cancer cell proliferation may pave the way for developing novel therapeutic strategies for treatment of ovarian cancer. SKOV3 cell,treated without rhSTIP1 SKOV3 cell,treated with rhSTIP1 SKOV3 cell,treated without rhSTIP1-2 SKOV3 cell,treated with rhSTIP1-2

2013-03-09 | E-GEOD-36383 | biostudies-arrayexpress

rhSTIP1 induced SAMD1/5 pathway

2013-03-09 | GSE36383 | GEO

Dppa2 synergizes with p53 in promoting DNA damage-induced apoptosis of mouse embryonic stem cells [ChIP-Seq]

Project description:Dppa2 (Developmental pluripotency associated 2), specifically expressed in embryonic stem cells (ESCs) and reactivated in certain cancers, plays important roles in regulating the transition between pluripotency and differentiation. However, its involvement in the DNA damage response (DDR) of mouse ESCs (mESCs) has remained unclear. Here, we identify a surprising pro-apoptotic function for Dppa2 as a novel p53-interacting partner in mESCs. Dppa2 physically interacts with p53 and is transcriptionally repressed by p53 upon DNA damage. By comparing the effects of Dppa2 in p53+/+ and p53-/- mESCs, we find that Dppa2 promotes DNA damage-induced apoptosis (DIA) of mESCs in a p53-dependent manner. RNA-seq and chromatin immunoprecipitation followed by sequencing (ChIP-seq) reveal that Dppa2 and p53 co-repress genes involved in cell cycle regulation and self-renewal, which are highly expressed in ESCs. Mechanistically, Dppa2 recruits p53 to the enhancers of these co-repressed genes. Consequently, Dppa2 depletion significantly compromises p53’s binding intensity and alleviates transcriptional repression. Collectively, our findings uncover a novel mechanism of p53-mediated apoptosis achieved through cooperation with its ESC-specific partner, Dppa2, thereby highlighting a previously unappreciated tumor suppressor identity of Dppa2.

2025-07-12 | GSE301903 | GEO

The PRC1 and PRC2 proximal interactome

Project description:Polycomb Repressive Complexes PRC1 and PRC2 play a crucial role in silencing lineage-specific genes during early embryogenesis. To provide new insights in polycomb biology, we profiled the proximal interactome (proxeome) of the catalytic subunits RNF2 (PRC1) and EZH2 (PRC2) in mouse embryonic stem cells (mESCs). This revealed >100 proteins proximal to PRC2 and PRC1, which mainly comprise transcription factors, transcriptional regulators and RNA binding proteins. Interestingly, the EZH2 proxeome included both PRC complexes, while the RNF2 proxeome only identified PRC1 subunits. More than half of the PRC2 proximal proteins are shared with PRC1, revealing the molecular constitution of polycomb chromatin domains. We identified several pluripotency-associated transcription factors, including NANOG, for which we confirmed genomic co-localisation with PRC2. Upon PRC2 disruption, NANOG redistributes to specific sites containing its DNA binding motif. Finally, we compared PRC2 proximal interactomes between naïve mESCs, serum-cultured mESCs and embryoid bodies, altogether providing a comprehensive resource in different cellular contexts that may help to further decipher Polycomb biology.

2025-02-25 | PXD047569 | Pride

The PRC1 and PRC2 proximal interactome

2025-02-25 | PXD058327 | Pride

The functional role of OGDH for maintaining mitochondrial respiration and identity of primed human embryonic stem cells

Project description:Human embryonic stem cells (hESCs) can self-renew infinitely or differentiate into the 3 germ layer lineages in vitro with certain cues, holding great promise to model early human embryo development ex vivo. It is wildly accepted that hESCs take advantage of both glycolysis and mitochondrial respiration to favor the naïve pluripotency, while prefer glycolysis to support the primed pluripotency. Thus, the function of mitochondrial respiration in primed hESCs has been underestimated for a long time, and has not been fully understood yet. Herein, we report that the adenosine triphosphate (ATP) production rate is comparable between mitochondrial respiration and glycolysis, suggesting that mitoATP may serve as one of the major sources of the ATP pool in primed hESCs. To further reveal the function of mitochondrial respiration, we deployed inducible CRISPRi method to inhibit OGDH expression with high efficiency, resulting in the TCA cycle blockade as well as the diminishment of mitochondrial respiration activity and total ATP level. Of note, OGDH deficiency led to the exit of primed pluripotency accompanied by cell death. Furthermore, the treatment with small molecule inhibitors to block electron transport chain (ETC) can phenocopy the loss-of-function of OGDH in hESCs. Therefore, genetic and pharmacological perturbations on mitochondrial respiration can impair the stemness of primed hESCs. Collectively, the current study unveils that OGDH acts as a key regulator to fine-tune the abundance of TCA cycle metabolites to ensure the mitochondrial respiration activity in primed hESCs, and highlights the pivotal roles of mitochondrial respiration in terms of ATP production and the maintenance of primed pluripotency. Our findings may provide insights into the linkage between pluripotent states and energy metabolism in hESCs.

2022-03-03 | MTBLS4223 | MetaboLights

Impact of eIF2α phosphorylation on the translational landscape of mouse embryonic stem cells [RNA-Seq]

Project description:The integrated stress response (ISR) is critical for cell survival under stress. In response to diverse environmental cues, eIF2αbecomes phosphorylated, engendering a dramatic change in mRNA translation. The activation of ISR plays a pivotal role in the early embryogenesis but the eIF2-dependent translational landscape in pluripotent embryonic stem cells (ESC) is largely unexplored. We employ a multi-omics approachconsisting of ribosome profiling, proteomics, and metabolomics inwild-type(eIF2α+/+)andphosphorylation-deficient mutant eIF2α(eIF2αA/A)mouse ESCs (mESCs) to investigate phosphorylated (p)-eIF2α-dependent translational control of naïve pluripotency. We show a transient increase in p-eIF2α in the naïve epiblast layer of E4.5 embryos. Absence of eIF2α phosphorylation engenders an exit from naive pluripotency following 2i (two chemical inhibitors of MEK1/2 and GSK3α/β) withdrawal. p-eIF2α controls translation of mRNAs encoding proteins which govern pluripotency, chromatin organization, and glutathione synthesis.Thus, p-eIF2αacts as a key regulator of the naïve pluripotency gene regulatory network.

2023-12-29 | GSE248725 | GEO